Asthma symptoms diagnosis and treatment
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
asthma AND treatment
Searching the Web
GINA 2026 asthma diagnosis treatment summary
Asthma
Asthma is a long-term condition in which the airways become inflamed and intermittently narrow. Symptoms may fluctuate and can be triggered by viral colds, allergens, smoke, exercise, cold air, pollution, or some medicines.
Common symptoms
- Wheeze, often worse at night or early morning
- Shortness of breath
- Chest tightness
- Cough, especially at night, with exercise, or after a cold
- Symptoms that vary over time and improve with a reliever inhaler
Not everyone with asthma wheezes, and wheeze can also occur with conditions other than asthma.
How it is diagnosed
A clinician combines:
-
Typical variable respiratory symptoms
Recurrent episodes of wheeze, breathlessness, chest tightness, and/or cough. -
Objective evidence of variable airflow limitation
Usually spirometry before and after a bronchodilator. A significant improvement after an inhaled bronchodilator supports asthma. When spirometry is normal, clinicians may use serial peak-flow readings, bronchial challenge testing, or repeat tests during symptoms. GINA recommends documenting both the symptom history and evidence of variable expiratory airflow before confirming the diagnosis when possible. GINA 2026 Summary Guide
Other possible causes may need consideration, for example COPD, vocal-cord dysfunction, heart disease, infection, reflux, or anxiety-related breathing symptoms.
Treatment
Treatment is individualized by age, symptom frequency, risk of severe attacks, inhaler technique, and lung-function results.
1. Inhaled corticosteroid (ICS) containing treatment is the foundation
ICS medicines reduce airway inflammation and lower the risk of severe exacerbations. Modern GINA guidance advises that adults and adolescents with asthma should receive an ICS-containing medication rather than using a short-acting reliever inhaler alone. GINA asthma guidance
ICS medicines reduce airway inflammation and lower the risk of severe exacerbations. Modern GINA guidance advises that adults and adolescents with asthma should receive an ICS-containing medication rather than using a short-acting reliever inhaler alone. GINA asthma guidance
2. Reliever medicine for symptoms
Depending on the prescribed plan, this may be:
Depending on the prescribed plan, this may be:
- Low-dose ICS-formoterol used as needed, often the preferred approach in many adults and adolescents
- Or a short-acting beta-agonist such as salbutamol/albuterol, but paired with regular or concurrent ICS treatment rather than used by itself
3. If symptoms remain uncontrolled
Clinicians step up treatment after checking diagnosis, inhaler technique, adherence, exposures such as smoking, and coexisting conditions. Options include:
Clinicians step up treatment after checking diagnosis, inhaler technique, adherence, exposures such as smoking, and coexisting conditions. Options include:
- Daily low-dose ICS or ICS-LABA combination inhaler
- Higher-dose controller therapy where needed
- Add-on long-acting muscarinic antagonist therapy in selected patients
- Specialist assessment and biologic treatments for severe allergic or eosinophilic asthma
4. Non-drug measures
- Learn and repeatedly check correct inhaler technique.
- Follow a written asthma action plan.
- Avoid tobacco smoke and vaping exposure.
- Identify relevant triggers, without unnecessary blanket avoidance.
- Keep vaccines and treatment for allergies, rhinitis, obesity, reflux, or sleep apnea up to date when relevant.
- Arrange regular review, even if symptoms are currently quiet.
During an asthma flare
Follow the person’s written action plan and use the prescribed reliever promptly. Seek urgent medical care if there is severe breathlessness, difficulty speaking full sentences, blue/gray lips, drowsiness or confusion, a “silent chest,” rapidly worsening symptoms, or inadequate response to reliever medication.
For a first episode of significant wheeze or shortness of breath, particularly with chest pain, fever, fainting, or symptoms at rest, seek prompt medical assessment rather than assuming it is asthma.
The medical-library references support that diagnosis requires compatible episodic symptoms plus evidence of variable airway obstruction, and that reversibility of obstruction is a key feature. Recent systematic reviews found in PubMed did not identify a general management finding that changes this core approach (PMIDs: 40562457, 38804437).
This is a shared conversation. Sign in to Orris to start your own chat.